Public Company News
SK Networks successfully hosts "SK Networks AI WAVE 2025" as part of its ongoing commitment to expanding the AI Ecosystem
- Under the theme 'Pitch the Future and Connect the Dots', the event brought together leadingAI startups and investors - The event showcased SK Networks' key AI portfolio companies, including Upstage and PhnyX Lab - A panel discussion on the future of Sovereign AI featured SK Networks' President ...
2025-09-18 20:00
2437
JinkoSolar Announces Completion of Sale of A Shares in Its Subsidiary, Jinko Solar Co., Ltd., through Inquiry Transfer and Placement
SHANGRAO, China, Sept. 18, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (" JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that the Company has completed the sale of 300,156,075 A shares of Jinko Solar ...
2025-09-18 18:51
2795
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2025. Second Quarter 2025 Highlights ...
2025-09-18 16:30
4689
iHuman and Cricket Media Team Up to Launch Reading Stars
Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectua...
2025-09-18 16:00
1991
Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2)
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...
2025-09-18 12:00
2045
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway
Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 17, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings...
2025-09-18 10:28
2167
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the updated long-term follow-up results of Phase I clinical trial of zevorcabtagene autoleucel (zevor-cel, R&D code...
2025-09-18 08:15
2361
NAVER CEO Choi Soo-yeon Appointed to UN Global Compact Board of Directors, Strengthening International Partnerships for "AI Governance"
- CEO Choi recognized for her leadership in global dialogues and cooperation to advance safe AI development and establish a digital ecosystem - Sanda Ojiambo, CEO and Executive Director of the UN Global Compact, said, "CEOChoi Soo-yeon's global leadership and deep expertise will be a great asset ...
2025-09-18 08:00
2820
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
--Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. --Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. Treatment emergent adverse events (TEAEs)...
2025-09-18 07:30
1950
Xiao-I Corporation Renews Strategic Partnership with Leading Global Bank to Elevate Digital Banking Experience
SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a global leader in artificial intelligence solutions, today announced the successful renewal of its strategic partnership with one of the world's premier financial institutions, a multinational banking organization renown...
2025-09-17 21:45
2738
Cheche Group Expands Partnership with Volkswagen Anhui, Delivering End-to-End Risk Management for New Energy Vehicles
BEIJING, Sept. 17, 2025 /PRNewswire/ -- Cheche Group Inc.
2025-09-17 20:30
5993
Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders
SHANGHAI and OAKLAND, Calif., Sept. 17, 2025 /PRNewswire/ -- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio today announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop2MW7141, a novel dual-target siRNA cand...
2025-09-17 20:00
1850
Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
* EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through its partner Qilu Pharmaceutical. DAEJEON, South Korea, Sept. 17, 2025 /PRNewswire/ -- Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has ...
2025-09-17 15:40
3230
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
* Maintained Quarterly Operational Profitability * Operating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoY * Maintained Positive Operating Cash Flow in the First Half of the Year SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a l...
2025-09-17 14:00
4718
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)
WUXI, China, Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi – MFG1, MFG2, and DP5 – have received GMP certification from Türkiye İlaç ve ...
2025-09-17 12:00
2134
Kexing Biopharm's Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Registered with FDA DMF
SHENZHEN, China, Sept. 16, 2025 /PRNewswire/ -- Kexing Biopharm announced that its investigational Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes has successfully completed a Type II Drug Master File (DMF) registration with the U.S. FDA. Exosomes, as a next-generation bioactive carr...
2025-09-17 10:30
2410
Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
- ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment. - ASC30 tablet's higher efficacy is supported by its higher oral drug exposures. - ASC30 is safe and well tolerated with only mild-...
2025-09-17 07:30
1894
LEVOIT AND BEST FRIENDS ANIMAL SOCIETY LAUNCH "PROTECT THEIR SANCTUARY" CAMPAIGN TO PROMOTE WELLNESS FOR PETS AND PEOPLE, SUPPORT NO-KILL EFFORTS
Home wellness brand pledges $100,000 and donates products to Best Friends,
supporting healthier, pet-friendly homes and lifesaving programs for pets
TUSTIN, Calif., Sept. 16, 2025 /PRNewswire/ -- Levoit™
2025-09-17 00:00
1826
Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025
Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC HLMHE session and WBS 2025 Leaders' Dialogue SEOUL, South Korea, Sept. 16, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announc...
2025-09-16 21:00
5359
Massimo Group Announces Launch of New Electric UTV for 2026, Expanding Into Growing EV Market
GARLAND, Texas, Sept. 16, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles, today announces the upcoming launch of its electric utility terrain vehicle (UTV), set to debut in 2026. This new model underscores the Company's commitment to meet...
2025-09-16 20:30
1631
Week's Top Stories
Most Reposted
MTR Lab and ZGC Science City Ltd Establish Ecosystem Partnership
[Picked up by 310 media titles]
2026-03-18 12:00
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
[Picked up by 301 media titles]
2026-03-17 08:00The Mastercard Collection: Savor the Extraordinary with Mastercard's Asia Gourmet Circle Program
[Picked up by 296 media titles]
2026-03-12 09:00Beijing InfoComm China 2026 Conference Lineup Presents Future of AI in Tech Aligning with the Nation's Next Strategic Five-Year Plan
[Picked up by 294 media titles]
2026-03-18 08:00
Agoda and Gangwon State Join Hands to Elevate Gangwon into a Premier Global Travel Destination
[Picked up by 293 media titles]
2026-03-17 11:29
Most Read
HTCO Launches U.S. Strategic Initiative Led by Chairman Christopher Nixon Cox, Establishes Independent Governance Committee for U.S. Operations
2026-03-13 21:30
7264
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
2026-03-13 21:59
6789